Klinikum im Friedrichshain

Futó vizsgálatok

• Toboroz

  Zanidatamab in Combination With Pembrolizumab and Chemotherapy in HER2 and PD-L1 Positive Metastatic Gastroesophageal Adenocarcinoma (GEA) Patients

  NCT07176312· 2. fázis· Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest· Forrás

• Toboroz

  A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carboplatin or Cisplatin in Participants With Previously Untreated, KRAS G12C-Mutated, Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer

  NCT06793215· 3. fázis· Hoffmann-La Roche· Forrás

• Toboroz

  A Study of Ifinatamab Deruxtecan in Subjects With Pretreated Advanced or Metastatic Esophageal Squamous Cell Carcinoma (ESCC) (IDeate-Esophageal01)

  NCT06644781· 3. fázis· Daiichi Sankyo· Forrás

• Toboroz

  Study of Olomorasib (LY3537982) in Combination With Standard of Care in Participants With Resected or Unresectable KRAS G12C-mutant Non-Small Cell Lung Cancer

  NCT06890598· 3. fázis· Eli Lilly and Company· Forrás

• Toboroz

  Inari VISION Registry

  NCT06600542· Inari Medical· Forrás

• Toboroz

  Study of TDXd, Chemotherapy, Pembrolizumab, and Trastuzumab in First-Line Metastatic HER2-Positive Gastric or Gastroesophageal Junction Cancer

  NCT06731478· 3. fázis· Daiichi Sankyo· Forrás

• Fut, nem toboroz

  A Study of Trastuzumab DeRuxtecan for Patients With Advanced HER2-pOsitive GaStric or GastroesoPhageal Junction AdEnocarcinoma Who Have Received a PrIor Trastuzumab-based Regimen Accompanied by a Disease RegistrY of Patients Treated With Conventional Therapies (PROSPERITY)

  NCT05993234· Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company· Forrás

• Fut, nem toboroz

  A Research Study Looking at Long-term Treatment With Mim8 in People With Haemophilia A

  NCT05685238· 3. fázis· Novo Nordisk A/S· Forrás

• Meghívásos bevonás

  Distal Evaluation of Functional Performance with Intravascular Sensors to Assess the Narrowing Effect: Guided Physiologic Stenting

  NCT04451044· Philips Clinical & Medical Affairs Global· Forrás

• Meghívásos bevonás

  A Study Following Males With Haemophilia A on Prophylaxis With Esperoct®

  NCT04574076· Novo Nordisk A/S· Forrás

• Fut, nem toboroz

  A Long-term Study of ADYNOVI/ADYNOVATE in Participants With Haemophilia A

  NCT04158934· Baxalta now part of Shire· Forrás

• Meghívásos bevonás

  A Study Following Males With Haemophilia B on Prophylaxis With Refixia/REBINYN

  NCT03745924· Novo Nordisk A/S· Forrás

• Fut, nem toboroz

  Reducing Lung CongestIon Symptoms in Advanced Heart Failure

  NCT03499236· V-Wave Ltd· Forrás

• Fut, nem toboroz

  The OCTOBER Trial - European Trial on Optical Coherence Tomography Optimized Bifurcation Event Reduction (OCTOBER)

  NCT03171311· Aarhus University Hospital Skejby· Forrás

• Toboroz

  The European Paediatric Network for Haemophilia Management ( PedNet Registry)

  NCT02979119· PedNet Haemophilia Research Foundation· Forrás

Egyszerre toboroz

Hány vizsgálat toboroz itt egyszerre ugyanarra az indikációra. Darabszám, nem értékelés.

• Gyomor- és nyelőcsőrák3 toboroz
• Hemofília3 toboroz
• Tüdőrák2 toboroz
• Deep vein thrombosis and pulmonary embolism1 toboroz
• Koszorúér-betegség1 toboroz

Lezárt vizsgálatok

• Lezárult

  Digitalized Clinical Decision Support for the Prevention of Postoperative Delirium (POD)

  NCT06445153· Charite University, Berlin, Germany· Forrás

• Lezárult

  A Research Study Investigating Mim8 in Adults and Adolescents With Haemophilia A With or Without Inhibitors

  NCT05053139· 3. fázis· Novo Nordisk A/S· Forrás

• Lezárult

  A Study of BAX 888 in Male Adults With Severe Hemophilia A

  NCT03370172· 1/2. fázis· Baxalta now part of Shire· Forrás

Betegségek

Betegségek, amelyekről az intézmény publikál vagy amelyekre vizsgálatot futtat.

• Hemofília14 munka · 7 vizsgálat